All Curated Mutation Sites in HSV2

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HSV2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: HSV-2 Infection-27056950

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	27056950	A1001G	UL5	UL5	HSV-2 Infection	R S	View
2	27056950	A739T	UL5	UL5	HSV-2 Infection	R S	View
3	27056950	C1281T	UL5	UL5	HSV-2 Infection	R S	View
4	27056950	C996T	UL5	UL5	HSV-2 Infection	R S	View
5	27056950	D513N	UL5	UL5	HSV-2 Infection	R S	View
6	27056950	G879A	UL5	UL5	HSV-2 Infection	R S	View
7	27056950	H334R	UL5	UL5	HSV-2 Infection	R S	View
8	27056950	I763V	UL5	UL5	HSV-2 Infection	R S	View
9	27056950	R415H	UL5	UL5	HSV-2 Infection	R S	View
10	27056950	S458G	UL5	UL5	HSV-2 Infection	R S	View
11	27056950	S605P	UL5	UL5	HSV-2 Infection	R S	View
12	27056950	S689T	UL5	UL5	HSV-2 Infection	R S	View
13	27056950	T1965G	UL5	UL5	HSV-2 Infection	R S	View
14	27056950	T2100C	UL5	UL5	HSV-2 Infection	R S	View
15	27056950	Y573H	UL5	UL5	HSV-2 Infection	R S	View
16	27056950	G1053A	UL5	UL5	HSV-2 Infection	R S	View
17	27056950	A578V	UL52	UL52	HSV-2 Infection	R S	View
18	27056950	A837G	UL52	UL52	HSV-2 Infection	R S	View
19	27056950	D58N	UL52	UL52	HSV-2 Infection	R S	View
20	27056950	D704G	UL52	UL52	HSV-2 Infection	R S	View
21	27056950	E101K	UL52	UL52	HSV-2 Infection	R S	View
22	27056950	E719A	UL52	UL52	HSV-2 Infection	R S	View
23	27056950	E9G	UL52	UL52	HSV-2 Infection	R S	View
24	27056950	G218A	UL52	UL52	HSV-2 Infection	R S	View
25	27056950	G312R	UL52	UL52	HSV-2 Infection	R S	View
26	27056950	G334S	UL52	UL52	HSV-2 Infection	R S	View
27	27056950	G430A	UL52	UL52	HSV-2 Infection	R S	View
28	27056950	G653C	UL52	UL52	HSV-2 Infection	R S	View
29	27056950	L600P	UL52	UL52	HSV-2 Infection	R S	View
30	27056950	N1020H	UL52	UL52	HSV-2 Infection	R S	View
31	27056950	R119H	UL52	UL52	HSV-2 Infection	R S	View
32	27056950	R331H	UL52	UL52	HSV-2 Infection	R S	View
33	27056950	R414S	UL52	UL52	HSV-2 Infection	R S	View
34	27056950	R424M	UL52	UL52	HSV-2 Infection	R S	View
35	27056950	R440C	UL52	UL52	HSV-2 Infection	R S	View
36	27056950	S459P	UL52	UL52	HSV-2 Infection	R S	View
37	27056950	S57P	UL52	UL52	HSV-2 Infection	R S	View
38	27056950	S697L	UL52	UL52	HSV-2 Infection	R S	View
39	27056950	T169C	UL52	UL52	HSV-2 Infection	R S	View
40	27056950	T25A	UL52	UL52	HSV-2 Infection	R S	View
41	27056950	T2862C	UL52	UL52	HSV-2 Infection	R S	View
42	27056950	T495S	UL52	UL52	HSV-2 Infection	R S	View
43	27056950	T518A	UL52	UL52	HSV-2 Infection	R S	View
44	27056950	V144I	UL52	UL52	HSV-2 Infection	R S	View
45	27056950	G2649A	UL52	UL52	HSV-2 Infection	R S	View
46	27056950	C2676T	UL52	UL52	HSV-2 Infection	R S	View

Contents
Description

The table shows all curated mutation sites of HSV2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.